Stilbene and fluorinated dialkylaminostilbene (FIDAS) considerably inhibited AR activity in prostate cancer cells co-transfected with constitutively active ARΔLBD-variant Q640X and an AR-dependent reporter gene [61]. This evidence concerns the gene AR and Familial prostate cancer.